Clinical trial
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
NCT04312763 is registered in ClinicalTrials.gov with Second Sight Medical Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
- Lead sponsor
- Second Sight Medical Products
- Phase
- Observational
- Overall status
- Suspended
- Start date
- March 6, 2020
- Completion date
- February 20, 2025
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blindness, acquired